- Home
- YB vs TRVI Comparison
YB vs TRVI Comparison
Compare YB & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YB
- TRVI
- Stock Information
- Founded
- YB 2019
- TRVI 2011
- Country
- YB China
- TRVI United States
- Employees
- YB N/A
- TRVI N/A
- Industry
- YB
- TRVI Biotechnology: Pharmaceutical Preparations
- Sector
- YB
- TRVI Health Care
- Exchange
- YB NYSE
- TRVI Nasdaq
- Market Cap
- YB 696.5M
- TRVI 629.8M
- IPO Year
- YB 2025
- TRVI 2019
- Fundamental
- Price
- YB $20.42
- TRVI $5.96
- Analyst Decision
- YB
- TRVI Strong Buy
- Analyst Count
- YB 0
- TRVI 8
- Target Price
- YB N/A
- TRVI $19.31
- AVG Volume (30 Days)
- YB 122.6K
- TRVI 2.6M
- Earning Date
- YB 06-05-2025
- TRVI 08-07-2025
- Dividend Yield
- YB N/A
- TRVI N/A
- EPS Growth
- YB N/A
- TRVI N/A
- EPS
- YB 3.12
- TRVI N/A
- Revenue
- YB $493,356,990.00
- TRVI N/A
- Revenue This Year
- YB N/A
- TRVI N/A
- Revenue Next Year
- YB N/A
- TRVI N/A
- P/E Ratio
- YB $6.54
- TRVI N/A
- Revenue Growth
- YB 59.97
- TRVI N/A
- 52 Week Low
- YB $14.04
- TRVI $2.36
- 52 Week High
- YB $28.99
- TRVI $7.48
- Technical
- Relative Strength Index (RSI)
- YB N/A
- TRVI 43.31
- Support Level
- YB N/A
- TRVI $6.05
- Resistance Level
- YB N/A
- TRVI $6.49
- Average True Range (ATR)
- YB 0.00
- TRVI 0.53
- MACD
- YB 0.00
- TRVI -0.05
- Stochastic Oscillator
- YB 0.00
- TRVI 27.62
About YB YUANBAO INC. SPON ADS EACH REP 6 CL A ORD
Yuanbao Inc is a technology-driven online insurance distributor in China.
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.